Umar Zubair, Nicole Battaglia, Julian E Alecu, Amy Tam, Joshua Rong, Vicente Quiroz, Kathryn Yang, Hyo-Min Kim, Kaitlyn Warren, Rebekah Mannix, Stefania Della Vecchia, Filippo Maria Santorelli, Darius Ebrahimi-Fakhari
{"title":"Elevated Plasma Neurofilament Light Chain Levels in Children with Infantile-Onset Ascending Hereditary Spastic Paralysis.","authors":"Umar Zubair, Nicole Battaglia, Julian E Alecu, Amy Tam, Joshua Rong, Vicente Quiroz, Kathryn Yang, Hyo-Min Kim, Kaitlyn Warren, Rebekah Mannix, Stefania Della Vecchia, Filippo Maria Santorelli, Darius Ebrahimi-Fakhari","doi":"10.1002/mdc3.70157","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Infantile-onset ascending hereditary spastic paralysis (IAHSP), caused by bi-allelic variants in ALS2, is an ultra-rare, neurodegenerative disorder characterized by progressive ascending spasticity and weakness with bulbar dysfunction.</p><p><strong>Objectives: </strong>To investigate baseline plasma neurofilament light chain (NfL) levels in children with IAHSP patients compared to age-matched controls.</p><p><strong>Methods: </strong>Five patients (age range: 6-11 years) with genetically confirmed IAHSP and 74 healthy controls were assessed. Plasma NfL was measured using a single-molecule array. Statistical analyses included non-parametric tests, age-matched comparisons, and effect size estimation.</p><p><strong>Results: </strong>Children with IAHSP had modestly but significantly elevated plasma NfL levels compared to controls (median: 17.5 vs. 4.78 pg/mL, p = 0.004). High NfL levels persisted across varying levels of clinical severity.</p><p><strong>Conclusions: </strong>Plasma NfL levels are elevated in IAHSP, suggesting axonal degeneration. These pilot findings highlight NfL as a potential marker for disease activity, warranting further investigation in larger cohorts and longitudinal studies.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Movement Disorders Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/mdc3.70157","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Infantile-onset ascending hereditary spastic paralysis (IAHSP), caused by bi-allelic variants in ALS2, is an ultra-rare, neurodegenerative disorder characterized by progressive ascending spasticity and weakness with bulbar dysfunction.
Objectives: To investigate baseline plasma neurofilament light chain (NfL) levels in children with IAHSP patients compared to age-matched controls.
Methods: Five patients (age range: 6-11 years) with genetically confirmed IAHSP and 74 healthy controls were assessed. Plasma NfL was measured using a single-molecule array. Statistical analyses included non-parametric tests, age-matched comparisons, and effect size estimation.
Results: Children with IAHSP had modestly but significantly elevated plasma NfL levels compared to controls (median: 17.5 vs. 4.78 pg/mL, p = 0.004). High NfL levels persisted across varying levels of clinical severity.
Conclusions: Plasma NfL levels are elevated in IAHSP, suggesting axonal degeneration. These pilot findings highlight NfL as a potential marker for disease activity, warranting further investigation in larger cohorts and longitudinal studies.
背景:婴幼儿起病的上升遗传性痉挛性麻痹(IAHSP)由ALS2的双等位基因变异引起,是一种极其罕见的神经退行性疾病,其特征是进行性上升性痉挛和无力伴球功能障碍。目的:研究IAHSP患儿血浆神经丝轻链(NfL)的基线水平,并与年龄匹配的对照组进行比较。方法:对5例遗传确诊的IAHSP患者(年龄6 ~ 11岁)和74例健康对照进行评估。使用单分子阵列测量血浆NfL。统计分析包括非参数检验、年龄匹配比较和效应大小估计。结果:与对照组相比,IAHSP患儿血浆NfL水平有中度但显著升高(中位数:17.5 vs. 4.78 pg/mL, p = 0.004)。高水平的NfL持续存在于不同的临床严重程度。结论:IAHSP患者血浆NfL水平升高,提示轴突变性。这些初步研究结果突出了NfL作为疾病活动的潜在标志物,值得在更大的队列和纵向研究中进一步调查。
期刊介绍:
Movement Disorders Clinical Practice- is an online-only journal committed to publishing high quality peer reviewed articles related to clinical aspects of movement disorders which broadly include phenomenology (interesting case/case series/rarities), investigative (for e.g- genetics, imaging), translational (phenotype-genotype or other) and treatment aspects (clinical guidelines, diagnostic and treatment algorithms)